Widely used in oligonucleotide synthesis, especially for the preparation of modified RNA strands. Its key role is in introducing a 2'-O,4'-C-methylene bridge into RNA, which enhances nuclease resistance and improves binding affinity to complementary sequences. This modification is critical in developing therapeutic antisense oligonucleotides, siRNA, and other RNA-based drugs where stability and specificity are essential. The DMTr (dimethoxytrityl) group enables efficient monitoring and purification during solid-phase synthesis, while the phosphoramidite moiety allows for automated coupling in DNA/RNA synthesizers. Commonly applied in research and pharmaceutical development for creating stable, high-affinity nucleic acid analogs.